nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—F2—atherosclerosis	0.509	1	CbGaD
Argatroban—CYP3A5—Rosuvastatin—atherosclerosis	0.0537	0.179	CbGbCtD
Argatroban—CYP3A5—Simvastatin—atherosclerosis	0.05	0.166	CbGbCtD
Argatroban—CYP3A5—Lovastatin—atherosclerosis	0.0489	0.162	CbGbCtD
Argatroban—CYP3A5—Pravastatin—atherosclerosis	0.0489	0.162	CbGbCtD
Argatroban—CYP3A4—Ezetimibe—atherosclerosis	0.021	0.0696	CbGbCtD
Argatroban—CYP3A4—Rosuvastatin—atherosclerosis	0.021	0.0696	CbGbCtD
Argatroban—CYP3A4—Simvastatin—atherosclerosis	0.0195	0.0647	CbGbCtD
Argatroban—CYP3A4—Pravastatin—atherosclerosis	0.0191	0.0633	CbGbCtD
Argatroban—CYP3A4—Lovastatin—atherosclerosis	0.0191	0.0633	CbGbCtD
Argatroban—F2—vein—atherosclerosis	0.0104	0.22	CbGeAlD
Argatroban—F2—leg—atherosclerosis	0.00776	0.163	CbGeAlD
Argatroban—F2—hindlimb—atherosclerosis	0.00693	0.146	CbGeAlD
Argatroban—F2—appendage—atherosclerosis	0.00594	0.125	CbGeAlD
Argatroban—F2—artery—atherosclerosis	0.00425	0.0895	CbGeAlD
Argatroban—F2—endothelium—atherosclerosis	0.00359	0.0756	CbGeAlD
Argatroban—Arterial thrombosis—Niacin—atherosclerosis	0.00337	0.0672	CcSEcCtD
Argatroban—F2—blood vessel—atherosclerosis	0.00331	0.0697	CbGeAlD
Argatroban—F2—connective tissue—atherosclerosis	0.0017	0.0357	CbGeAlD
Argatroban—F2—cardiovascular system—atherosclerosis	0.00148	0.0311	CbGeAlD
Argatroban—Haemoptysis—Niacin—atherosclerosis	0.00122	0.0245	CcSEcCtD
Argatroban—Gastrooesophageal reflux disease—Ezetimibe—atherosclerosis	0.00115	0.0229	CcSEcCtD
Argatroban—Renal failure acute—Rosuvastatin—atherosclerosis	0.000979	0.0196	CcSEcCtD
Argatroban—F2—liver—atherosclerosis	0.000913	0.0192	CbGeAlD
Argatroban—Atrial fibrillation—Simvastatin—atherosclerosis	0.000756	0.0151	CcSEcCtD
Argatroban—Renal failure acute—Pravastatin—atherosclerosis	0.000702	0.014	CcSEcCtD
Argatroban—Atrial fibrillation—Niacin—atherosclerosis	0.000694	0.0139	CcSEcCtD
Argatroban—Dermatitis bullous—Niacin—atherosclerosis	0.000689	0.0137	CcSEcCtD
Argatroban—Urinary tract infection—Rosuvastatin—atherosclerosis	0.000677	0.0135	CcSEcCtD
Argatroban—Haematuria—Rosuvastatin—atherosclerosis	0.000664	0.0133	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.000658	0.0131	CcSEcCtD
Argatroban—Urinary tract infection—Lovastatin—atherosclerosis	0.000574	0.0115	CcSEcCtD
Argatroban—Angina pectoris—Niacin—atherosclerosis	0.000554	0.0111	CcSEcCtD
Argatroban—Angina pectoris—Pravastatin—atherosclerosis	0.000546	0.0109	CcSEcCtD
Argatroban—CYP3A5—adipose tissue—atherosclerosis	0.000527	0.0111	CbGeAlD
Argatroban—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000492	0.00983	CcSEcCtD
Argatroban—Myocardial infarction—Pravastatin—atherosclerosis	0.000489	0.00977	CcSEcCtD
Argatroban—Urinary tract infection—Pravastatin—atherosclerosis	0.000485	0.00969	CcSEcCtD
Argatroban—Cough—Rosuvastatin—atherosclerosis	0.000475	0.00949	CcSEcCtD
Argatroban—Angiopathy—Ezetimibe—atherosclerosis	0.000472	0.00942	CcSEcCtD
Argatroban—Haemoglobin—Niacin—atherosclerosis	0.000458	0.00913	CcSEcCtD
Argatroban—Haemorrhage—Niacin—atherosclerosis	0.000455	0.00909	CcSEcCtD
Argatroban—Confusional state—Rosuvastatin—atherosclerosis	0.000448	0.00895	CcSEcCtD
Argatroban—Back pain—Lovastatin—atherosclerosis	0.000446	0.00891	CcSEcCtD
Argatroban—Infection—Rosuvastatin—atherosclerosis	0.000441	0.00881	CcSEcCtD
Argatroban—Back pain—Ezetimibe—atherosclerosis	0.000438	0.00874	CcSEcCtD
Argatroban—Angiopathy—Niacin—atherosclerosis	0.000413	0.00825	CcSEcCtD
Argatroban—Cough—Ezetimibe—atherosclerosis	0.000395	0.00788	CcSEcCtD
Argatroban—Chest pain—Lovastatin—atherosclerosis	0.000393	0.00784	CcSEcCtD
Argatroban—Dyspepsia—Rosuvastatin—atherosclerosis	0.000391	0.00781	CcSEcCtD
Argatroban—Chest pain—Ezetimibe—atherosclerosis	0.000385	0.00769	CcSEcCtD
Argatroban—Constipation—Rosuvastatin—atherosclerosis	0.00038	0.00759	CcSEcCtD
Argatroban—Pain—Rosuvastatin—atherosclerosis	0.00038	0.00759	CcSEcCtD
Argatroban—Confusional state—Lovastatin—atherosclerosis	0.00038	0.00758	CcSEcCtD
Argatroban—Infection—Lovastatin—atherosclerosis	0.000374	0.00747	CcSEcCtD
Argatroban—Confusional state—Ezetimibe—atherosclerosis	0.000372	0.00744	CcSEcCtD
Argatroban—CYP3A5—liver—atherosclerosis	0.00037	0.00779	CbGeAlD
Argatroban—Chest pain—Simvastatin—atherosclerosis	0.000367	0.00734	CcSEcCtD
Argatroban—Infection—Ezetimibe—atherosclerosis	0.000367	0.00733	CcSEcCtD
Argatroban—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000366	0.00731	CcSEcCtD
Argatroban—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000363	0.00725	CcSEcCtD
Argatroban—Confusional state—Simvastatin—atherosclerosis	0.000355	0.00709	CcSEcCtD
Argatroban—Abdominal pain—Rosuvastatin—atherosclerosis	0.000351	0.00701	CcSEcCtD
Argatroban—Infection—Simvastatin—atherosclerosis	0.00035	0.00699	CcSEcCtD
Argatroban—Cough—Niacin—atherosclerosis	0.000346	0.0069	CcSEcCtD
Argatroban—Cough—Pravastatin—atherosclerosis	0.000341	0.0068	CcSEcCtD
Argatroban—Dyspnoea—Lovastatin—atherosclerosis	0.000336	0.0067	CcSEcCtD
Argatroban—Chest pain—Pravastatin—atherosclerosis	0.000332	0.00663	CcSEcCtD
Argatroban—Dyspepsia—Lovastatin—atherosclerosis	0.000332	0.00662	CcSEcCtD
Argatroban—Dyspnoea—Ezetimibe—atherosclerosis	0.000329	0.00657	CcSEcCtD
Argatroban—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000327	0.00654	CcSEcCtD
Argatroban—Dyspepsia—Ezetimibe—atherosclerosis	0.000325	0.00649	CcSEcCtD
Argatroban—Constipation—Lovastatin—atherosclerosis	0.000322	0.00643	CcSEcCtD
Argatroban—Pain—Lovastatin—atherosclerosis	0.000322	0.00643	CcSEcCtD
Argatroban—Confusional state—Pravastatin—atherosclerosis	0.000321	0.00641	CcSEcCtD
Argatroban—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000319	0.00637	CcSEcCtD
Argatroban—Infection—Pravastatin—atherosclerosis	0.000316	0.00632	CcSEcCtD
Argatroban—Pain—Ezetimibe—atherosclerosis	0.000316	0.00631	CcSEcCtD
Argatroban—Constipation—Ezetimibe—atherosclerosis	0.000316	0.00631	CcSEcCtD
Argatroban—Tachycardia—Niacin—atherosclerosis	0.000316	0.0063	CcSEcCtD
Argatroban—Dyspnoea—Simvastatin—atherosclerosis	0.000314	0.00627	CcSEcCtD
Argatroban—Feeling abnormal—Lovastatin—atherosclerosis	0.00031	0.0062	CcSEcCtD
Argatroban—Dyspepsia—Simvastatin—atherosclerosis	0.00031	0.00619	CcSEcCtD
Argatroban—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000308	0.00615	CcSEcCtD
Argatroban—Feeling abnormal—Ezetimibe—atherosclerosis	0.000304	0.00608	CcSEcCtD
Argatroban—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000304	0.00607	CcSEcCtD
Argatroban—Diarrhoea—Rosuvastatin—atherosclerosis	0.000304	0.00607	CcSEcCtD
Argatroban—Hypotension—Niacin—atherosclerosis	0.000302	0.00603	CcSEcCtD
Argatroban—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000302	0.00603	CcSEcCtD
Argatroban—Pain—Simvastatin—atherosclerosis	0.000301	0.00601	CcSEcCtD
Argatroban—Constipation—Simvastatin—atherosclerosis	0.000301	0.00601	CcSEcCtD
Argatroban—Abdominal pain—Lovastatin—atherosclerosis	0.000298	0.00594	CcSEcCtD
Argatroban—Body temperature increased—Lovastatin—atherosclerosis	0.000298	0.00594	CcSEcCtD
Argatroban—Dizziness—Rosuvastatin—atherosclerosis	0.000294	0.00587	CcSEcCtD
Argatroban—Body temperature increased—Ezetimibe—atherosclerosis	0.000292	0.00583	CcSEcCtD
Argatroban—Abdominal pain—Ezetimibe—atherosclerosis	0.000292	0.00583	CcSEcCtD
Argatroban—Feeling abnormal—Simvastatin—atherosclerosis	0.00029	0.00579	CcSEcCtD
Argatroban—Dyspnoea—Niacin—atherosclerosis	0.000288	0.00576	CcSEcCtD
Argatroban—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000288	0.00575	CcSEcCtD
Argatroban—Dyspepsia—Niacin—atherosclerosis	0.000285	0.00568	CcSEcCtD
Argatroban—Dyspnoea—Pravastatin—atherosclerosis	0.000284	0.00567	CcSEcCtD
Argatroban—Dyspepsia—Pravastatin—atherosclerosis	0.00028	0.0056	CcSEcCtD
Argatroban—Rash—Rosuvastatin—atherosclerosis	0.00028	0.00559	CcSEcCtD
Argatroban—Dermatitis—Rosuvastatin—atherosclerosis	0.00028	0.00559	CcSEcCtD
Argatroban—Gastrointestinal disorder—Niacin—atherosclerosis	0.000279	0.00557	CcSEcCtD
Argatroban—Body temperature increased—Simvastatin—atherosclerosis	0.000278	0.00556	CcSEcCtD
Argatroban—Abdominal pain—Simvastatin—atherosclerosis	0.000278	0.00556	CcSEcCtD
Argatroban—Headache—Rosuvastatin—atherosclerosis	0.000278	0.00556	CcSEcCtD
Argatroban—Hypersensitivity—Lovastatin—atherosclerosis	0.000277	0.00554	CcSEcCtD
Argatroban—CYP3A4—liver—atherosclerosis	0.000277	0.00584	CbGeAlD
Argatroban—Pain—Niacin—atherosclerosis	0.000277	0.00552	CcSEcCtD
Argatroban—Pain—Pravastatin—atherosclerosis	0.000272	0.00544	CcSEcCtD
Argatroban—Constipation—Pravastatin—atherosclerosis	0.000272	0.00544	CcSEcCtD
Argatroban—Hypersensitivity—Ezetimibe—atherosclerosis	0.000272	0.00543	CcSEcCtD
Argatroban—Gastrointestinal pain—Niacin—atherosclerosis	0.000265	0.00528	CcSEcCtD
Argatroban—Nausea—Rosuvastatin—atherosclerosis	0.000264	0.00527	CcSEcCtD
Argatroban—Feeling abnormal—Pravastatin—atherosclerosis	0.000262	0.00524	CcSEcCtD
Argatroban—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00026	0.0052	CcSEcCtD
Argatroban—Hypersensitivity—Simvastatin—atherosclerosis	0.00026	0.00518	CcSEcCtD
Argatroban—Diarrhoea—Lovastatin—atherosclerosis	0.000258	0.00514	CcSEcCtD
Argatroban—Body temperature increased—Niacin—atherosclerosis	0.000256	0.0051	CcSEcCtD
Argatroban—Abdominal pain—Niacin—atherosclerosis	0.000256	0.0051	CcSEcCtD
Argatroban—Diarrhoea—Ezetimibe—atherosclerosis	0.000253	0.00505	CcSEcCtD
Argatroban—Abdominal pain—Pravastatin—atherosclerosis	0.000252	0.00503	CcSEcCtD
Argatroban—Body temperature increased—Pravastatin—atherosclerosis	0.000252	0.00503	CcSEcCtD
Argatroban—Dizziness—Lovastatin—atherosclerosis	0.000249	0.00497	CcSEcCtD
Argatroban—Dizziness—Ezetimibe—atherosclerosis	0.000244	0.00488	CcSEcCtD
Argatroban—Diarrhoea—Simvastatin—atherosclerosis	0.000241	0.00481	CcSEcCtD
Argatroban—Vomiting—Lovastatin—atherosclerosis	0.000239	0.00478	CcSEcCtD
Argatroban—Hypersensitivity—Niacin—atherosclerosis	0.000238	0.00476	CcSEcCtD
Argatroban—Rash—Lovastatin—atherosclerosis	0.000237	0.00474	CcSEcCtD
Argatroban—Dermatitis—Lovastatin—atherosclerosis	0.000237	0.00474	CcSEcCtD
Argatroban—Headache—Lovastatin—atherosclerosis	0.000236	0.00471	CcSEcCtD
Argatroban—Vomiting—Ezetimibe—atherosclerosis	0.000235	0.00469	CcSEcCtD
Argatroban—Hypersensitivity—Pravastatin—atherosclerosis	0.000235	0.00468	CcSEcCtD
Argatroban—Dizziness—Simvastatin—atherosclerosis	0.000233	0.00465	CcSEcCtD
Argatroban—Rash—Ezetimibe—atherosclerosis	0.000233	0.00465	CcSEcCtD
Argatroban—Dermatitis—Ezetimibe—atherosclerosis	0.000233	0.00465	CcSEcCtD
Argatroban—Headache—Ezetimibe—atherosclerosis	0.000231	0.00462	CcSEcCtD
Argatroban—Vomiting—Simvastatin—atherosclerosis	0.000224	0.00447	CcSEcCtD
Argatroban—Nausea—Lovastatin—atherosclerosis	0.000224	0.00447	CcSEcCtD
Argatroban—Rash—Simvastatin—atherosclerosis	0.000222	0.00443	CcSEcCtD
Argatroban—Dermatitis—Simvastatin—atherosclerosis	0.000222	0.00443	CcSEcCtD
Argatroban—Diarrhoea—Niacin—atherosclerosis	0.000221	0.00442	CcSEcCtD
Argatroban—Headache—Simvastatin—atherosclerosis	0.000221	0.00441	CcSEcCtD
Argatroban—Nausea—Ezetimibe—atherosclerosis	0.000219	0.00438	CcSEcCtD
Argatroban—Diarrhoea—Pravastatin—atherosclerosis	0.000218	0.00435	CcSEcCtD
Argatroban—Dizziness—Niacin—atherosclerosis	0.000214	0.00427	CcSEcCtD
Argatroban—Dizziness—Pravastatin—atherosclerosis	0.000211	0.0042	CcSEcCtD
Argatroban—Nausea—Simvastatin—atherosclerosis	0.000209	0.00418	CcSEcCtD
Argatroban—Vomiting—Niacin—atherosclerosis	0.000206	0.00411	CcSEcCtD
Argatroban—Rash—Niacin—atherosclerosis	0.000204	0.00407	CcSEcCtD
Argatroban—Dermatitis—Niacin—atherosclerosis	0.000204	0.00407	CcSEcCtD
Argatroban—Headache—Niacin—atherosclerosis	0.000203	0.00405	CcSEcCtD
Argatroban—Vomiting—Pravastatin—atherosclerosis	0.000202	0.00404	CcSEcCtD
Argatroban—Rash—Pravastatin—atherosclerosis	0.000201	0.00401	CcSEcCtD
Argatroban—Dermatitis—Pravastatin—atherosclerosis	0.000201	0.004	CcSEcCtD
Argatroban—Headache—Pravastatin—atherosclerosis	0.0002	0.00398	CcSEcCtD
Argatroban—Nausea—Niacin—atherosclerosis	0.000192	0.00384	CcSEcCtD
Argatroban—Nausea—Pravastatin—atherosclerosis	0.000189	0.00378	CcSEcCtD
Argatroban—F2—Signaling by GPCR—CCL4—atherosclerosis	6.16e-05	0.000669	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—UTS2—atherosclerosis	6.04e-05	0.000656	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—SERPINE1—atherosclerosis	5.91e-05	0.000643	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—ALB—atherosclerosis	5.9e-05	0.000641	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IL6—atherosclerosis	5.88e-05	0.000639	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	5.82e-05	0.000633	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	5.81e-05	0.000631	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CASR—atherosclerosis	5.79e-05	0.000629	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	5.73e-05	0.000622	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—F7—atherosclerosis	5.7e-05	0.000619	CbGpPWpGaD
Argatroban—F2—Hemostasis—KNG1—atherosclerosis	5.67e-05	0.000616	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—CXCL8—atherosclerosis	5.65e-05	0.000614	CbGpPWpGaD
Argatroban—F2—Hemostasis—PLAUR—atherosclerosis	5.62e-05	0.00061	CbGpPWpGaD
Argatroban—F2—Hemostasis—PLG—atherosclerosis	5.49e-05	0.000597	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—UTS2—atherosclerosis	5.49e-05	0.000596	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CNR2—atherosclerosis	5.39e-05	0.000585	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	5.37e-05	0.000583	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—EDN1—atherosclerosis	5.34e-05	0.00058	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCL5—atherosclerosis	5.3e-05	0.000576	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	5.29e-05	0.000575	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—MAPK3—atherosclerosis	5.28e-05	0.000573	CbGpPWpGaD
Argatroban—F2—Hemostasis—SOD1—atherosclerosis	5.26e-05	0.000572	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CX3CR1—atherosclerosis	5.26e-05	0.000572	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CASR—atherosclerosis	5.26e-05	0.000572	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CX3CL1—atherosclerosis	5.16e-05	0.00056	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTM1—atherosclerosis	5.16e-05	0.00056	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSTM1—atherosclerosis	5.09e-05	0.000553	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—GHRL—atherosclerosis	5.08e-05	0.000552	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HRH1—atherosclerosis	5.03e-05	0.000546	CbGpPWpGaD
Argatroban—F2—Hemostasis—IGF2—atherosclerosis	5e-05	0.000543	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—ACE—atherosclerosis	4.92e-05	0.000535	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CNR2—atherosclerosis	4.89e-05	0.000531	CbGpPWpGaD
Argatroban—F2—Hemostasis—APOB—atherosclerosis	4.85e-05	0.000527	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	4.8e-05	0.000521	CbGpPWpGaD
Argatroban—F2—Hemostasis—PRKCG—atherosclerosis	4.51e-05	0.00049	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—AGT—atherosclerosis	4.43e-05	0.000482	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—PLAUR—atherosclerosis	4.42e-05	0.00048	CbGpPWpGaD
Argatroban—F2—Hemostasis—CD36—atherosclerosis	4.4e-05	0.000478	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—PLG—atherosclerosis	4.32e-05	0.000469	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL3—atherosclerosis	4.21e-05	0.000457	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCR2—atherosclerosis	4.19e-05	0.000455	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—EDNRA—atherosclerosis	4.19e-05	0.000455	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—GHRL—atherosclerosis	4.08e-05	0.000443	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	4.07e-05	0.000442	CbGpPWpGaD
Argatroban—F2—Hemostasis—PDGFB—atherosclerosis	4.06e-05	0.000441	CbGpPWpGaD
Argatroban—F2—Hemostasis—MMP1—atherosclerosis	4.02e-05	0.000436	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOA4—atherosclerosis	3.95e-05	0.000429	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	3.93e-05	0.000427	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—IGF2—atherosclerosis	3.93e-05	0.000427	CbGpPWpGaD
Argatroban—F2—Hemostasis—CAV1—atherosclerosis	3.85e-05	0.000418	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	3.85e-05	0.000418	CbGpPWpGaD
Argatroban—F2—Hemostasis—APOA1—atherosclerosis	3.84e-05	0.000417	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EDNRA—atherosclerosis	3.8e-05	0.000413	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCR2—atherosclerosis	3.8e-05	0.000413	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	3.79e-05	0.000412	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	3.73e-05	0.000406	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—GHRL—atherosclerosis	3.71e-05	0.000403	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LDLRAP1—atherosclerosis	3.66e-05	0.000397	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCL2—atherosclerosis	3.65e-05	0.000397	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL4—atherosclerosis	3.64e-05	0.000395	CbGpPWpGaD
Argatroban—F2—Hemostasis—NOS2—atherosclerosis	3.62e-05	0.000393	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—KNG1—atherosclerosis	3.58e-05	0.000389	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AGTR1—atherosclerosis	3.56e-05	0.000387	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CG—atherosclerosis	3.51e-05	0.000381	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PLTP—atherosclerosis	3.44e-05	0.000374	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOA2—atherosclerosis	3.4e-05	0.000369	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—KNG1—atherosclerosis	3.25e-05	0.000353	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—UTS2—atherosclerosis	3.24e-05	0.000352	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AGTR1—atherosclerosis	3.23e-05	0.000351	CbGpPWpGaD
Argatroban—F2—Hemostasis—IGF1—atherosclerosis	3.21e-05	0.000349	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—MMP1—atherosclerosis	3.16e-05	0.000343	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—AGT—atherosclerosis	3.12e-05	0.000339	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CX3CR1—atherosclerosis	3.11e-05	0.000338	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASR—atherosclerosis	3.11e-05	0.000338	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—LEP—atherosclerosis	3.06e-05	0.000332	CbGpPWpGaD
Argatroban—F2—Hemostasis—SERPINE1—atherosclerosis	3.05e-05	0.000331	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CX3CL1—atherosclerosis	3.05e-05	0.000331	CbGpPWpGaD
Argatroban—F2—Hemostasis—ALB—atherosclerosis	3.04e-05	0.000331	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—EDN1—atherosclerosis	3.02e-05	0.000328	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCL5—atherosclerosis	3e-05	0.000325	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCG8—atherosclerosis	2.98e-05	0.000324	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LTA4H—atherosclerosis	2.98e-05	0.000324	CbGpPWpGaD
Argatroban—F2—Hemostasis—NOS3—atherosclerosis	2.91e-05	0.000316	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CNR2—atherosclerosis	2.89e-05	0.000314	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCL8—atherosclerosis	2.89e-05	0.000314	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MMP3—atherosclerosis	2.88e-05	0.000313	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	2.88e-05	0.000312	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PRKCG—atherosclerosis	2.85e-05	0.000309	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EDN1—atherosclerosis	2.74e-05	0.000298	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL5—atherosclerosis	2.72e-05	0.000296	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—INS—atherosclerosis	2.61e-05	0.000284	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	2.6e-05	0.000282	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PRKCG—atherosclerosis	2.59e-05	0.000281	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VWF—atherosclerosis	2.57e-05	0.00028	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CCL2—atherosclerosis	2.57e-05	0.000279	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOC3—atherosclerosis	2.56e-05	0.000278	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LDLR—atherosclerosis	2.54e-05	0.000276	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—IGF1—atherosclerosis	2.53e-05	0.000274	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AGT—atherosclerosis	2.51e-05	0.000272	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL3—atherosclerosis	2.48e-05	0.00027	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—MMP2—atherosclerosis	2.44e-05	0.000266	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	2.4e-05	0.000261	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NCF1—atherosclerosis	2.38e-05	0.000258	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	2.37e-05	0.000257	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCG1—atherosclerosis	2.36e-05	0.000256	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AGT—atherosclerosis	2.28e-05	0.000247	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EDNRA—atherosclerosis	2.25e-05	0.000244	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCR2—atherosclerosis	2.25e-05	0.000244	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CYBA—atherosclerosis	2.24e-05	0.000243	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CG—atherosclerosis	2.22e-05	0.000241	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LCAT—atherosclerosis	2.22e-05	0.000241	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—FABP4—atherosclerosis	2.22e-05	0.000241	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GHRL—atherosclerosis	2.19e-05	0.000238	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PLAT—atherosclerosis	2.19e-05	0.000238	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PARP1—atherosclerosis	2.19e-05	0.000238	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOA4—atherosclerosis	2.17e-05	0.000236	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP7A1—atherosclerosis	2.14e-05	0.000232	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—atherosclerosis	2.1e-05	0.000228	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CXCL8—atherosclerosis	2.03e-05	0.000221	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CG—atherosclerosis	2.01e-05	0.000219	CbGpPWpGaD
Argatroban—F2—Hemostasis—MAPK3—atherosclerosis	1.98e-05	0.000216	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP27A1—atherosclerosis	1.97e-05	0.000215	CbGpPWpGaD
Argatroban—F2—Hemostasis—TGFB1—atherosclerosis	1.92e-05	0.000209	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KNG1—atherosclerosis	1.92e-05	0.000209	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AGTR1—atherosclerosis	1.91e-05	0.000208	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL2—atherosclerosis	1.87e-05	0.000204	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALOX5AP—atherosclerosis	1.87e-05	0.000203	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PLA2G2A—atherosclerosis	1.87e-05	0.000203	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALOX15—atherosclerosis	1.87e-05	0.000203	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOA2—atherosclerosis	1.87e-05	0.000203	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PLG—atherosclerosis	1.86e-05	0.000202	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCG5—atherosclerosis	1.85e-05	0.000201	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LPA—atherosclerosis	1.79e-05	0.000194	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SOCS3—atherosclerosis	1.76e-05	0.000192	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—BGN—atherosclerosis	1.73e-05	0.000188	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOA5—atherosclerosis	1.71e-05	0.000186	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP3—atherosclerosis	1.7e-05	0.000185	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.7e-05	0.000185	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF2—atherosclerosis	1.7e-05	0.000184	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PLA2G1B—atherosclerosis	1.65e-05	0.000179	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOB—atherosclerosis	1.65e-05	0.000179	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCL8—atherosclerosis	1.63e-05	0.000177	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EDN1—atherosclerosis	1.62e-05	0.000176	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL5—atherosclerosis	1.61e-05	0.000175	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLTP—atherosclerosis	1.6e-05	0.000174	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALOX5—atherosclerosis	1.59e-05	0.000173	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LPL—atherosclerosis	1.57e-05	0.000171	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PRKCG—atherosclerosis	1.53e-05	0.000166	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SPP1—atherosclerosis	1.49e-05	0.000162	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCL8—atherosclerosis	1.48e-05	0.000161	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.43e-05	0.000155	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LIPC—atherosclerosis	1.42e-05	0.000154	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOC3—atherosclerosis	1.41e-05	0.000153	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LDLR—atherosclerosis	1.4e-05	0.000152	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.39e-05	0.000151	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.39e-05	0.000151	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PDGFB—atherosclerosis	1.38e-05	0.00015	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CETP—atherosclerosis	1.37e-05	0.000149	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AGT—atherosclerosis	1.34e-05	0.000146	CbGpPWpGaD
Argatroban—F2—Hemostasis—AKT1—atherosclerosis	1.34e-05	0.000145	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOE—atherosclerosis	1.32e-05	0.000143	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LEP—atherosclerosis	1.32e-05	0.000143	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.31e-05	0.000142	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CAV1—atherosclerosis	1.31e-05	0.000142	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOA1—atherosclerosis	1.3e-05	0.000141	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ESR1—atherosclerosis	1.26e-05	0.000137	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.24e-05	0.000134	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CG—atherosclerosis	1.19e-05	0.000129	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAPK3—atherosclerosis	1.14e-05	0.000124	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—INS—atherosclerosis	1.13e-05	0.000122	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL2—atherosclerosis	1.11e-05	0.00012	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.1e-05	0.00012	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.1e-05	0.000119	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF1—atherosclerosis	1.09e-05	0.000118	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SERPINE1—atherosclerosis	1.03e-05	0.000112	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—FABP4—atherosclerosis	1.03e-05	0.000112	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LCAT—atherosclerosis	1.03e-05	0.000112	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOA4—atherosclerosis	1.01e-05	0.00011	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP7A1—atherosclerosis	9.93e-06	0.000108	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOS3—atherosclerosis	9.87e-06	0.000107	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HMOX1—atherosclerosis	9.47e-06	0.000103	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP27A1—atherosclerosis	9.18e-06	9.97e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOB—atherosclerosis	9.07e-06	9.85e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTM1—atherosclerosis	8.82e-06	9.58e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL8—atherosclerosis	8.75e-06	9.51e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	8.7e-06	9.46e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOA2—atherosclerosis	8.7e-06	9.46e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALOX15—atherosclerosis	8.7e-06	9.46e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	8.7e-06	9.46e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LPL—atherosclerosis	8.66e-06	9.41e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCG5—atherosclerosis	8.6e-06	9.34e-05	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AKT1—atherosclerosis	8.46e-06	9.19e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GPX1—atherosclerosis	8.45e-06	9.18e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—atherosclerosis	8.32e-06	9.04e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LPA—atherosclerosis	8.3e-06	9.02e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CD36—atherosclerosis	8.23e-06	8.94e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—BGN—atherosclerosis	8.04e-06	8.74e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOA5—atherosclerosis	7.96e-06	8.65e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP9—atherosclerosis	7.92e-06	8.6e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NFKB1—atherosclerosis	7.83e-06	8.51e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MTHFR—atherosclerosis	7.8e-06	8.47e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK8—atherosclerosis	7.7e-06	8.36e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AKT1—atherosclerosis	7.68e-06	8.34e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	7.66e-06	8.32e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARA—atherosclerosis	7.65e-06	8.31e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AGT—atherosclerosis	7.41e-06	8.05e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.4e-06	8.04e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOE—atherosclerosis	7.26e-06	7.88e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CAV1—atherosclerosis	7.19e-06	7.81e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOA1—atherosclerosis	7.17e-06	7.79e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—atherosclerosis	7.11e-06	7.72e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT3—atherosclerosis	7.04e-06	7.65e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK3—atherosclerosis	6.73e-06	7.31e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NAMPT—atherosclerosis	6.64e-06	7.21e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LIPC—atherosclerosis	6.6e-06	7.17e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOC3—atherosclerosis	6.56e-06	7.12e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CG—atherosclerosis	6.55e-06	7.12e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TGFB1—atherosclerosis	6.53e-06	7.09e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LDLR—atherosclerosis	6.52e-06	7.08e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CETP—atherosclerosis	6.36e-06	6.91e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARG—atherosclerosis	6.32e-06	6.87e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—INS—atherosclerosis	6.2e-06	6.74e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.09e-06	6.62e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.76e-06	6.25e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALB—atherosclerosis	5.68e-06	6.18e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NOS3—atherosclerosis	5.44e-06	5.91e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.13e-06	5.57e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTGS2—atherosclerosis	4.97e-06	5.4e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—atherosclerosis	4.92e-06	5.34e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKT1—atherosclerosis	4.54e-06	4.93e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.4e-06	4.78e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOB—atherosclerosis	4.22e-06	4.58e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.1e-06	4.46e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LPL—atherosclerosis	4.03e-06	4.37e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GPX1—atherosclerosis	3.93e-06	4.27e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CD36—atherosclerosis	3.82e-06	4.16e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.62e-06	3.94e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARA—atherosclerosis	3.56e-06	3.86e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AGT—atherosclerosis	3.44e-06	3.74e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOE—atherosclerosis	3.37e-06	3.67e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CAV1—atherosclerosis	3.34e-06	3.63e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOA1—atherosclerosis	3.34e-06	3.62e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.05e-06	3.31e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARG—atherosclerosis	2.94e-06	3.19e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—INS—atherosclerosis	2.88e-06	3.13e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALB—atherosclerosis	2.64e-06	2.87e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NOS3—atherosclerosis	2.53e-06	2.75e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AKT1—atherosclerosis	2.5e-06	2.72e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.31e-06	2.51e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AKT1—atherosclerosis	1.16e-06	1.26e-05	CbGpPWpGaD
